DRTS
Alpha Tau Medical (DRTS)
$81
About Alpha Tau Medical (DRTS)
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Details
Daily high
$5.21
Daily low
$4.72
Price at open
$5.18
52 Week High
$5.21
52 Week Low
$2.30
Market cap
438.3M
Dividend yield
0.00%
Volume
198,949
Avg. volume
257,791
P/E ratio
-9.86
Alpha Tau Medical News
Details
Daily high
$5.21
Daily low
$4.72
Price at open
$5.18
52 Week High
$5.21
52 Week Low
$2.30
Market cap
438.3M
Dividend yield
0.00%
Volume
198,949
Avg. volume
257,791
P/E ratio
-9.86